J M BURKMAN & ASSOCIATES

Lobbying for APARTES PHARMACEUTICALS · A leading North American pharma company with innovative new products.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Ontario · House · Senate · $290,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Issues at HHS and FDA, Federal contracting issues, DOD contracting.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.